Introduction
Methods
Study population
Trial interventions
Coronary angiography
CMR
CMR analysis
Statistical analysis
Results
Study population
Total (n = 301) | Missing (n) | Women (n = 66) | Missing (n) | Men (n = 235) | Missing (n) | p-value | |
---|---|---|---|---|---|---|---|
Age, years | 61 ± 12 | 0 | 67 ± 10 | 0 | 60 ± 12 | 0 | < 0.001 |
Pain to balloon, min | 184 ± 73 | 103 | 194 ± 78 | 35 | 182 ± 72 | 68 | 0.376 |
Pre PCI TnT < 15 ng/L, % | 48 | 5 | 38 | 3 | 51 | 2 | 0.089 |
Risk factors | |||||||
Current smoker, % | 39 | 9 | 37 | 1 | 39 | 8 | 0.774 |
Smoker or ex-smoker, % | 59 | 9 | 62 | 0 | 55 | 0 | 0.399 |
Diabetes, % | 12 | 0 | 20 | 0 | 9 | 0 | 0.029 |
Hypertension, % | 30 | 1 | 42 | 1 | 26 | 0 | 0.022 |
Treatments | |||||||
Hypothermia, % | 16 | 0 | 14 | 0 | 17 | 0 | 0.576 |
Oxygen, % | 48 | 206a | 53 | 34 | 46 | 172 | 0.524 |
TRO40303, % | 18 | 0 | 11 | 0 | 20 | 0 | 0.101 |
Angiography | |||||||
Anterior injury, % | 42 | 1 | 37 | 1 | 43 | 0 | 0.395 |
TIMI 0, % | 76 | 1 | 73 | 0 | 76 | 1 | 0.520 |
Rentrop 0, % | 66 | 9 | 73 | 4 | 68 | 15 | 0.536 |
CMR | |||||||
LVM, g | 126 ± 28 | 0 | 106 ± 30 | 0 | 132 ± 24 | 0 | < 0.001 |
LVM/BSA, g/m2 | 65 ± 14 | 0 | 60 ± 18 | 0 | 66 ± 12 | 0 | 0.001 |
MaR, % of LVM | 34 ± 11 | 3 | 30 ± 11 | 0 | 35 ± 11 | 3 | 0.001 |
Infarct, % of LVM | 17 ± 10 | 16 | 13 ± 10 | 2 | 18 ± 10 | 14 | < 0.001 |
MSI, % of MaR | 53 ± 20 | 19 | 61 ± 20 | 2 | 51 ± 20 | 17 | 0.001 |
Myocardium at risk
MaR | Infarct size | MSI | |||||||
---|---|---|---|---|---|---|---|---|---|
Coeff | SE | p-value | Coeff | SE | p-value | Coeff | SE | p-value | |
Age | 0.0 | 0.1 | 0.866 | 0.1 | 0.1 | 0.213 | − 0.2 | 0.1 | 0.059 |
Pain to balloon | 0.0 | 0.0 | 0.262 | 0.0 | 0.0 | 0.512 | −0.0 | 0.0 | 0.143 |
Female gender | −5.0 | 1.5 | 0.001 | −5.0 | 1.4 | < 0.001 | 9.8 | 2.8 | 0.001 |
Pre PCI TnT < 15 ng/L | 1.0 | 1.3 | 0.419 | −1.8 | 1.2 | 0.148 | 5.8 | 2.4 | 0.015 |
LVM | 0.1 | 0.0 | 0.004 | 0.1 | 0.0 | < 0.001 | −0.2 | 0.0 | < 0.001 |
LVM/BSA | 0.1 | 0.0 | 0.053 | 0.1 | 0.0 | 0.001 | −0.3 | 0.1 | 0.001 |
Risk factors | |||||||||
Current smoker | −1.0 | 1.3 | 0.465 | −2.4 | 1.3 | 0.057 | 3.8 | 2.5 | 0.138 |
Smoker or ex-smoker | −1.5 | 1.3 | 0.237 | −2.8 | 1.2 | 0.021 | 5.3 | 2.4 | 0.030 |
Diabetes | −0.7 | 2.0 | 0.719 | −0.1 | 1.9 | 0.972 | 0.0 | 3.8 | 0.997 |
Hypertension | 0.1 | 1.4 | 0.966 | 0.1 | 1.3 | 0.936 | −0.2 | 2.7 | 0.929 |
Treatments | |||||||||
Hypothermia | 2.8 | 1.7 | 0.100 | −0.2 | 1.6 | 0.882 | 3.0 | 3.2 | 0.357 |
Oxygen | 2.2 | 2.3 | 0.346 | −0.2 | 2.2 | 0.940 | 3.7 | 5.0 | 0.467 |
TRO40303 | 1.4 | 1.7 | 0.408 | 1.0 | 1.6 | 0.544 | −1.7 | 3.2 | 0.603 |
Angiography | |||||||||
Anterior injury | 10.9 | 1.1 | < 0.001 | 9.0 | 1.1 | < 0.001 | −9.4 | 2.4 | < 0.001 |
TIMI 0 | 3.5 | 1.5 | 0.019 | 5.7 | 1.3 | < 0.001 | −12.4 | 2.7 | < 0.001 |
Rentrop 0 | −3.4 | 1.4 | 0.018 | −2.0 | 1.4 | 0.139 | 0.4 | 2.7 | 0.894 |
Variable | Regression coefficient | SE | Partial correlation | p-value |
---|---|---|---|---|
Model r2 = 33 | ||||
Female gender | −3.5 | 1.4 | −0.1 | 0.015 |
Anterior injury | 11.5 | 1.1 | 0.5 | < 0.001 |
Hypothermia | 4.1 | 1.5 | 0.1 | 0.005 |
TIMI 0 | 3.2 | 1.3 | 0.1 | 0.014 |
Rentrop 0 | −2.0 | 1.2 | −0.1 | 0.095 |
LVM | −0.0 | 0.0 | −0.0 | 0.707 |
Infarct
Variable | Regression coefficient | SE | Partial correlation | p-value |
---|---|---|---|---|
Model r2 = 0.29 | ||||
Female gender | −3.2 | 1.4 | −0.1 | 0.018 |
Current smoker | 0.2 | 1.5 | 0.0 | 0.896 |
Smoker or ex-smoker | −1.9 | 1.4 | −0.1 | 0.192 |
Anterior injury | 8.4 | 1.1 | 0.4 | < 0.001 |
TIMI 0 | 5.3 | 1.2 | 0.2 | < 0.001 |
LVM | 0.0 | 0.0 | 0.1 | 0.217 |
Myocardial salvage
Variable | Regression coefficient | SE | Partial correlation | p-value |
---|---|---|---|---|
Model r2 = 0.20 | ||||
Age | −0.2 | 0.1 | −0.1 | 0.064 |
Female gender | 9.1 | 3.0 | 0.2 | 0.002 |
Smoker or ex-smoker | 2.5 | 2.3 | 0.1 | 0.270 |
Anterior injury | −6.5 | 2.3 | −0.2 | 0.005 |
TIMI 0 | −12.0 | 2.6 | −0.3 | < 0.001 |
Pre PCI TnT < 15 ng/L | 5.3 | 2.3 | 0.1 | 0.022 |
LVM | −0.1 | 0.0 | −0.1 | 0.133 |